• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄增长是肺栓塞溶栓后出血并发症的主要危险因素。

Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.

作者信息

Mikkola K M, Patel S R, Parker J A, Grodstein F, Goldhaber S Z

机构信息

School of Medicine, Lund University, Sweden.

出版信息

Am Heart J. 1997 Jul;134(1):69-72. doi: 10.1016/s0002-8703(97)70108-x.

DOI:10.1016/s0002-8703(97)70108-x
PMID:9266785
Abstract

We reviewed our database of 312 patients with pulmonary embolism who received thrombolysis in five clinical trials. At baseline, none had a history of stroke, internal bleeding within 6 months, surgery within 10 days, or occult blood in stool. Sixty-six major bleeding episodes occurred within 72 hours of administering thrombolysis in 61 (20%) patients: bleeding at the catheterization site (34 cases), gross hematuria (9), intracranial hemorrhage (5), and 18 other bleeding episodes that led to at least a 10% hematocrit decrease. Patients with a major bleeding complication were on average older than patients with no hemorrhagic complication (mean age 62.9 +/- 1.9 years vs 56.2 +/- 1.1 years; p = 0.005). In an adjusted analysis, there was a fourfold increased risk of bleeding among patients older than 70 years compared with patients younger than 50 years (relative risk [RR] 3.9; 95% confidence interval [CI] 1.7 to 8.9). By using age as a continuous variable, we found a 4% (RR 1.04; 95% CI 1.02 to 1.06) increase in risk of bleeding for each incremental year of age. In addition, patients with higher body mass index had an increased risk of bleeding. Patients who had undergone catheterization had a five times greater risk of bleeding (RR 5.2; 95% CI 1.5 to 17.8). In summary, increasing age, larger body mass index, and catheterization predisposed to bleeding complications after pulmonary embolism thrombolysis.

摘要

我们回顾了我们数据库中312例在五项临床试验中接受溶栓治疗的肺栓塞患者。基线时,无一例有中风病史、6个月内有内出血、10天内有手术史或大便潜血。61例(20%)患者在溶栓治疗后72小时内发生了66次严重出血事件:导管插入部位出血(34例)、肉眼血尿(9例)、颅内出血(5例)以及其他18次导致血细胞比容至少降低10%的出血事件。发生严重出血并发症的患者平均年龄高于无出血并发症的患者(平均年龄62.9±1.9岁对56.2±1.1岁;p=0.005)。在一项校正分析中,70岁以上患者的出血风险比50岁以下患者增加了四倍(相对风险[RR]3.9;95%置信区间[CI]1.7至8.9)。将年龄作为连续变量,我们发现年龄每增加一岁,出血风险增加4%(RR 1.04;95%CI 1.02至1.06)。此外,体重指数较高的患者出血风险增加。接受过导管插入术的患者出血风险高五倍(RR 5.2;95%CI 1.5至17.8)。总之,年龄增加、体重指数增大和导管插入术易导致肺栓塞溶栓后出血并发症。

相似文献

1
Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.年龄增长是肺栓塞溶栓后出血并发症的主要危险因素。
Am Heart J. 1997 Jul;134(1):69-72. doi: 10.1016/s0002-8703(97)70108-x.
2
Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients.老年大面积肺栓塞患者溶栓治疗的安全性:与非老年患者的比较
J Am Coll Cardiol. 1993 Oct;22(4):1075-9. doi: 10.1016/0735-1097(93)90418-z.
3
[Fibrinolysis in pulmonary embolism].[肺栓塞中的纤维蛋白溶解]
Presse Med. 2001 Oct 20;30(30):1501-6.
4
Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patients with massive pulmonary embolism.
Am J Med. 1998 Dec;105(6):472-7. doi: 10.1016/s0002-9343(98)00355-6.
5
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis.溶栓治疗与肝素治疗肺栓塞的疗效比较:基于临床结局的荟萃分析
Arch Intern Med. 2002;162(22):2537-41. doi: 10.1001/archinte.162.22.2537.
6
A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.重组尿激酶与血管手术作为腿部急性动脉闭塞初始治疗方法的比较。溶栓或外周动脉手术(TOPAS)研究人员。
N Engl J Med. 1998 Apr 16;338(16):1105-11. doi: 10.1056/NEJM199804163381603.
7
Catheter-directed, ultrasound-assisted thrombolysis is a safe and effective treatment for pulmonary embolism, even in high-risk patients.经导管、超声辅助溶栓治疗是一种安全有效的肺栓塞治疗方法,即使在高危患者中也是如此。
J Vasc Surg Venous Lymphat Disord. 2017 Mar;5(2):165-170. doi: 10.1016/j.jvsv.2016.10.075. Epub 2017 Jan 12.
8
Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.使用尿激酶和重组组织型纤溶酶原激活剂进行导管定向外周动脉和静脉溶栓相关的并发症。
J Vasc Interv Radiol. 2000 Mar;11(3):295-8. doi: 10.1016/s1051-0443(07)61420-1.
9
[Complications of thrombolytic therapy in pulmonary embolism].[肺栓塞溶栓治疗的并发症]
Arch Mal Coeur Vaiss. 1995 Nov;88(11 Suppl):1769-76.
10
Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?肺栓塞的溶栓治疗:是否有效?是否安全?何时适用?
Arch Intern Med. 1997;157(22):2550-6.

引用本文的文献

1
Intermediate-Risk Pulmonary Embolism: Patients' Stratification, Prognosis, and Therapeutic Options-Time to Pay Attention to the Middle Child.中危肺栓塞:患者分层、预后及治疗选择——是时候关注中间的孩子了。
J Clin Med. 2025 Sep 3;14(17):6215. doi: 10.3390/jcm14176215.
2
Efficacy and Safety of Systemic Thrombolysis and Catheter-Directed Therapy in Pulmonary Embolism: A Narrative Review.全身溶栓和导管定向治疗在肺栓塞中的疗效与安全性:一项叙述性综述
Cureus. 2024 Nov 20;16(11):e74086. doi: 10.7759/cureus.74086. eCollection 2024 Nov.
3
Recurrent High-Risk Pulmonary Thromboembolism Treated with Repeated Thrombolytic Therapy Could be Helpful for Certain Patients: A Case Report and Review of the Literature.
重复溶栓治疗复发性高危肺血栓栓塞症可能对某些患者有益:一例病例报告及文献复习
Eur J Case Rep Intern Med. 2023 Aug 25;10(9):004042. doi: 10.12890/2023_004042. eCollection 2023.
4
Reduced-Dose Systemic Fibrinolysis in Massive Pulmonary Embolism: A Pilot Study.大剂量肺栓塞中低剂量全身纤溶治疗:一项初步研究。
Clin Exp Emerg Med. 2023 Sep;10(3):280-286. doi: 10.15441/ceem.23.015. Epub 2023 May 15.
5
Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update.衰老在静脉血栓栓塞症中的病理生理学:更新。
Medicina (Kaunas). 2022 Aug 10;58(8):1078. doi: 10.3390/medicina58081078.
6
Thrombolytic Therapy in Octogenarians with Acute Pulmonary Embolism.八旬急性肺栓塞患者的溶栓治疗。
Arq Bras Cardiol. 2022 Jan;118(1):68-74. doi: 10.36660/abc.20201060.
7
Advanced therapies and extracorporeal membrane oxygenation for the management of high-risk pulmonary embolism.用于高危肺栓塞管理的先进疗法和体外膜肺氧合
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):195-200. doi: 10.1182/hematology.2020000167.
8
Catheter-based Therapy for Massive Pulmonary Embolism in an Elderly Woman with Chest Pain and Dyspnea: Case Report.老年胸痛伴呼吸困难女性的导管介入治疗大规模肺栓塞:病例报告
Cureus. 2019 Sep 26;11(9):e5771. doi: 10.7759/cureus.5771.
9
The Efficacy and Safety of Intermittent Low-Dose Urokinase Thrombolysis for the Treatment of Senile Acute Intermediate-High-Risk Pulmonary Embolism: A Pilot Trial.间歇性小剂量尿激酶溶栓治疗老年急性中高危肺栓塞的疗效与安全性:一项试点试验
Clin Appl Thromb Hemost. 2018 Oct;24(7):1067-1072. doi: 10.1177/1076029618758953. Epub 2018 Mar 18.
10
Management of intra-operative acute pulmonary embolism during general anesthesia: a case report.全身麻醉期间术中急性肺栓塞的处理:一例报告
BMC Anesthesiol. 2017 May 26;17(1):67. doi: 10.1186/s12871-017-0360-0.